Waters Corporation (WAT) Shares Bought by AHL Partners LLP

AHL Partners LLP lifted its holdings in Waters Corporation (NYSE:WAT) by 167.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,893 shares of the medical instruments supplier’s stock after buying an additional 14,322 shares during the quarter. AHL Partners LLP’s holdings in Waters Corporation were worth $4,209,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Oppenheimer Asset Management Inc. raised its holdings in shares of Waters Corporation by 0.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after buying an additional 2 shares during the last quarter. Diversified Trust Co raised its holdings in shares of Waters Corporation by 0.4% in the second quarter. Diversified Trust Co now owns 1,285 shares of the medical instruments supplier’s stock valued at $236,000 after buying an additional 5 shares during the last quarter. Alps Advisors Inc. raised its holdings in shares of Waters Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 3,062 shares of the medical instruments supplier’s stock valued at $563,000 after buying an additional 8 shares during the last quarter. Cleararc Capital Inc. raised its holdings in shares of Waters Corporation by 0.6% in the first quarter. Cleararc Capital Inc. now owns 1,950 shares of the medical instruments supplier’s stock valued at $305,000 after buying an additional 11 shares during the last quarter. Finally, Lowe Brockenbrough & Co. Inc. raised its holdings in shares of Waters Corporation by 0.8% in the second quarter. Lowe Brockenbrough & Co. Inc. now owns 1,528 shares of the medical instruments supplier’s stock valued at $281,000 after buying an additional 12 shares during the last quarter. 91.00% of the stock is owned by institutional investors and hedge funds.

WAT has been the subject of a number of research analyst reports. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 price target for the company in a report on Thursday, July 13th. BidaskClub cut Waters Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $175.00 price target on shares of Waters Corporation in a report on Thursday, July 27th. Deutsche Bank AG cut Waters Corporation from a “buy” rating to a “hold” rating and lifted their price target for the company from $183.00 to $194.00 in a report on Monday, July 10th. Finally, Cowen and Company reaffirmed a “hold” rating and issued a $190.00 price target on shares of Waters Corporation in a report on Friday, July 14th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $186.25.

In other news, Director Christopher A. Kuebler sold 3,500 shares of the firm’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total transaction of $628,845.00. Following the completion of the transaction, the director now directly owns 17,849 shares in the company, valued at $3,206,929.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Rohit Khanna sold 18,400 shares of the firm’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $185.78, for a total value of $3,418,352.00. Following the transaction, the senior vice president now owns 22,477 shares of the company’s stock, valued at $4,175,777.06. The disclosure for this sale can be found here. Company insiders own 5.07% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://ledgergazette.com/2017/10/09/waters-corporation-wat-shares-bought-by-ahl-partners-llp.html.

Shares of Waters Corporation (NYSE:WAT) opened at 185.88 on Monday. The company has a market capitalization of $14.84 billion, a PE ratio of 28.02 and a beta of 0.82. The firm’s 50-day moving average price is $183.15 and its 200 day moving average price is $176.36. Waters Corporation has a one year low of $133.35 and a one year high of $190.39.

Waters Corporation (NYSE:WAT) last announced its quarterly earnings results on Tuesday, July 25th. The medical instrume

Several other institutional investors have also added to or reduced their stakes in the stock. Oppenheimer Asset Management Inc. raised its holdings in shares of Waters Corporation by 0.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after buying an additional 2 shares during the last quarter. Diversified Trust Co raised its holdings in shares of Waters Corporation by 0.4% in the second quarter. Diversified Trust Co now owns 1,285 shares of the medical instruments supplier’s stock valued at $236,000 after buying an additional 5 shares during the last quarter. Alps Advisors Inc. raised its holdings in shares of Waters Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 3,062 shares of the medical instruments supplier’s stock valued at $563,000 after buying an additional 8 shares during the last quarter. Cleararc Capital Inc. raised its holdings in shares of Waters Corporation by 0.6% in the first quarter. Cleararc Capital Inc. now owns 1,950 shares of the medical instruments supplier’s stock valued at $305,000 after buying an additional 11 shares during the last quarter. Finally, Lowe Brockenbrough & Co. Inc. raised its holdings in shares of Waters Corporation by 0.8% in the second quarter. Lowe Brockenbrough & Co. Inc. now owns 1,528 shares of the medical instruments supplier’s stock valued at $281,000 after buying an additional 12 shares during the last quarter. 91.00% of the stock is owned by institutional investors and hedge funds.

WAT has been the subject of a number of research analyst reports. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 price target for the company in a report on Thursday, July 13th. BidaskClub cut Waters Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $175.00 price target on shares of Waters Corporation in a report on Thursday, July 27th. Deutsche Bank AG cut Waters Corporation from a “buy” rating to a “hold” rating and lifted their price target for the company from $183.00 to $194.00 in a report on Monday, July 10th. Finally, Cowen and Company reaffirmed a “hold” rating and issued a $190.00 price target on shares of Waters Corporation in a report on Friday, July 14th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $186.25.

In other news, Director Christopher A. Kuebler sold 3,500 shares of the firm’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total transaction of $628,845.00. Following the completion of the transaction, the director now directly owns 17,849 shares in the company, valued at $3,206,929.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Rohit Khanna sold 18,400 shares of the firm’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $185.78, for a total value of $3,418,352.00. Following the transaction, the senior vice president now owns 22,477 shares of the company’s stock, valued at $4,175,777.06. The disclosure for this sale can be found here. Company insiders own 5.07% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://ledgergazette.com/2017/10/09/waters-corporation-wat-shares-bought-by-ahl-partners-llp.html.

Shares of Waters Corporation (NYSE:WAT) opened at 185.88 on Monday. The company has a market capitalization of $14.84 billion, a PE ratio of 28.02 and a beta of 0.82. The firm’s 50-day moving average price is $183.15 and its 200 day moving average price is $176.36. Waters Corporation has a one year low of $133.35 and a one year high of $190.39.

Waters Corporation (NYSE:WAT) last announced its quarterly earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 EPS for the quarter, beating the Zacks’ consensus estimate of $1.71 by $0.05. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The firm had revenue of $558.30 million for the quarter, compared to analyst estimates of $553.22 million. During the same period last year, the firm posted $1.58 earnings per share. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. Analysts anticipate that Waters Corporation will post $7.39 earnings per share for the current year.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Institutional Ownership by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply